検索結果 20,805 件中 1 件 〜 50 件 "finance"
  1. 2020060409694

    POLITICS NATIONAL SAFETY COUNCIL CORONA Minister of Cooperation Development, Digital Agenda, Postal services and Finance Alexander De Croo (C) arrives for a meeting of the National Safety Council, consisting of politicians and intelligence services, to discuss tackling the COVID-19 (Coronavirus) pandemic, Wednesday 03 June 2020 in Brussels.BELGA PHOTO POOL OLIVIER HOSLET、クレジット:BELGA/共同通信イメージズ 「BELGA」

  2. 2020060210483

    邦銀の海外投融資に警鐘  日本の金融機関のCLO保有状況

  3. 2020060210479

    邦銀の海外投融資に警鐘  日本の金融機関のCLO保有状況

  4. 2020060210424

    シンガポールで制限緩和 シンガポールの金融街  通勤時間帯、人通りが少ないシンガポールの金融街=2日(共同)

  5. 2020060400662

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process A woman looks on as President & Chief Executive Officer CivicaRx, Martin VanTrieste, speaks by video conference during a United States Senate Finance Committee hearing on “COVID-19 and Beyond: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process“ at the US Capitol in Washington, DC on June 2, 2020.Credit: Andrew Caballero-Reynolds / Pool via CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  6. 2020060400650

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process United States Senator John Thune (Republican of South Dakota) looks on during a US Senate Finance Committee hearing on “COVID-19 and Beyond: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process“ at the US Capitol in Washington, DC on June 2, 2020.Credit: Andrew Caballero-Reynolds / Pool via CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  7. 2020060401169

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process United States Senator Chuck Grassley (Republican of Iowa) speaks during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  8. 2020060401411

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process United States Senator John Cornyn (Republican of Texas) speaks during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  9. 2020060401422

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), speaks during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  10. 2020060401534

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), speaks during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  11. 2020060401513

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration (FDA) speaks via teleconference during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  12. 2020060401102

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), speaks during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  13. 2020060400623

    Madrid, Spain; 02/06/2020.- First Council of Ministers with journalists in... Madrid, Spain; 02/06/2020.- First Council of Ministers with journalists in the Complex room of La Moncloa (seat of the government of the Kingdom of Spain) since the declaration of the state of alarm and that prove to request the sixth extension of the state of alarm.The Minister of Finance and spokesperson, María Jesús Montero, the Vice President of Ecological Transition, Teresa Ribera, and the Minister of Health, Salvador Illa (picture), appear before the Council of Ministers in which, among other things, it has been approved to request the sixth and last extension of the alarm status. The Government agrees to present a decree law before June 15 that will regulate the exit from the state of alarm for the territories that reach the new normality.Photo: POOL Edu Parra/ Juan Carlos Rojas/Picture Alliance | usage worldwide、クレジット:Juan Carlos Rojas/DPA/共同通信イメージズ 「DPA」

  14. 2020060400596

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo looks on during a United States Senate Finance Committee hearing on “COVID-19 and Beyond: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process“ at the US Capitol in Washington, DC on June 2, 2020.Credit: Andrew Caballero-Reynolds / Pool via CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  15. 2020060400599

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo speaks during a United States Senate Finance Committee hearing on “COVID-19 and Beyond: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process“ at the US Capitol in Washington, DC on June 2, 2020.Credit: Andrew Caballero-Reynolds / Pool via CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  16. 2020060400616

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process United States Senator Chuck Grassley (Republican of Iowa) speaks with an aide during a United States Senate Finance Committee hearing on “COVID-19 and Beyond: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process“ at the US Capitol in Washington, DC on June 2, 2020.Credit: Andrew Caballero-Reynolds / Pool via CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  17. 2020060400632

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process United States Senator Chuck Grassley (Republican of Iowa) arrives for a US Senate Finance Committee hearing on “COVID-19 and Beyond: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process“ at the US Capitol in Washington, DC on June 2, 2020.Credit: Andrew Caballero-Reynolds / Pool via CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  18. 2020060400760

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin speaks during a United States Senate Finance Committee hearing on “COVID-19 and Beyond: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process“ at the US Capitol in Washington, DC on June 2, 2020.Credit: Andrew Caballero-Reynolds / Pool via CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  19. 2020060400771

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo speaks during a United States Senate Finance Committee hearing on “COVID-19 and Beyond: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process“ at the US Capitol in Washington, DC on June 2, 2020.Credit: Andrew Caballero-Reynolds / Pool via CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  20. 2020060401147

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  21. 2020060401130

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), speaks during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  22. 2020060401121

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), listens during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  23. 2020060401128

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA) listens during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  24. 2020060401142

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  25. 2020060401560

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process United States Senator Chuck Grassley (Republican of Iowa) adjusts his protective face mask prior to the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  26. 2020060401552

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process United States Senator Steve Daines (Republican of Montana) listens during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  27. 2020060400734

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process United States Senator Ben Sasse (Republican of Nebraska) looks on during a US Senate Finance Committee hearing on “COVID-19 and Beyond: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process“ at the US Capitol in Washington, DC on June 2, 2020.Credit: Andrew Caballero-Reynolds / Pool via CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  28. 2020060400724

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process United States Senator Debbie Stabenow (Democrat of Michigan) asks a question by video conference during a United States Senate Finance Committee hearing on “COVID-19 and Beyond: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process“ at the US Capitol in Washington, DC on June 2, 2020.Credit: Andrew Caballero-Reynolds / Pool via CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  29. 2020060400741

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process Judith A. McMeekin, Pharm.D., Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs, Food and Drug Administration and Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo (L) look on during a United States Senate Finance Committee hearing on “COVID-19 and Beyond: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process“ at the US Capitol in Washington, DC on June 2, 2020.Credit: Andrew Caballero-Reynolds / Pool via CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  30. 2020060400711

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin looks on as Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo speaks during a United States Senate Finance Committee hearing on “COVID-19 and Beyond: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process“ at the US Capitol in Washington, DC on June 2, 2020.Credit: Andrew Caballero-Reynolds / Pool via CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  31. 2020060400730

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin and Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo look on during a United States Senate Finance Committee hearing on “COVID-19 and Beyond: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process“ at the US Capitol in Washington, DC on June 2, 2020.Credit: Andrew Caballero-Reynolds / Pool via CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  32. 2020060400718

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin (R) and Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo look on during a United States Senate Finance Committee hearing on “COVID-19 and Beyond: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process“ at the US Capitol in Washington, DC on June 2, 2020.Credit: Andrew Caballero-Reynolds / Pool via CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  33. 2020060401233

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process United States Senator Tom Carper (Democrat of Delaware), center, speaks to Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration FDA), before leaving the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  34. 2020060401471

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration (FDA) speaks via teleconference during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  35. 2020060400929

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process David Light, Founder and CEO of Valisure, listens during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  36. 2020060401076

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process United States Senator Ron Wyden (Democrat of Oregon) speaks via teleconference during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  37. 2020060401065

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), speaks during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  38. 2020060401328

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA) listens during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  39. 2020060401334

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process United States Senator John Cornyn (Republican of Texas) speaks during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  40. 2020060400706

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo speaks during a United States Senate Finance Committee hearing on “COVID-19 and Beyond: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process“ at the US Capitol in Washington, DC on June 2, 2020.Credit: Andrew Caballero-Reynolds / Pool via CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  41. 2020060400950

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process David Light, Founder and CEO of Valisure, listens during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  42. 2020060400939

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process David Light, Founder and CEO of Valisure, listens during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  43. 2020060400955

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process United States Senator Ben Sasse (Republican of Nebraska) listens during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  44. 2020060401098

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), speaks during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  45. 2020060401073

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process United States Senator Tom Carper (Democrat of Delaware) speaks during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  46. 2020060401078

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  47. 2020060400748

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process United States Senator Pat Toomey (Republican of Pennsylvania) asks a question by video conference during a Senate Finance Committee hearing on “COVID-19 and Beyond: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process“ at the US Capitol in Washington, DC on June 2, 2020.Credit: Andrew Caballero-Reynolds / Pool via CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  48. 2020060400726

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo speaks during a United States Senate Finance Committee hearing on “COVID-19 and Beyond: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process“ at the US Capitol in Washington, DC on June 2, 2020.Credit: Andrew Caballero-Reynolds / Pool via CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  49. 2020060401030

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process United States Senator Ron Wyden (Democrat of Oregon) speaks via teleconference during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Credit: Stefani Reynolds / CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

  50. 2020060400614

    U.S. Senate Hearing: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process Founder and CEO Valisure, David Light, looks on during a United States Senate Finance Committee hearing on “COVID-19 and Beyond: Oversight of the FDA‘s Foreign Drug Manufacturing Inspection Process“ at the US Capitol in Washington, DC on June 2, 2020.Credit: Andrew Caballero-Reynolds / Pool via CNP | usage worldwide、クレジット:CNP/DPA/共同通信イメージズ 「DPA」

さらに表示 取得中
検索中です
[チャプター再生]
本画像はログイン後にご覧いただけます
商品コード: タイトル情報無
※このコンテンツはプレミアム価格対象商品です。料金はコンテンツにより異なります。
タグ

登録日時 撮影日 種別
提供元

データサイズ

画像サイズ 解像度
展開サイズ※
フレームサイズ フレームレート
再生時間 映像形式
音声有無 映像有無
※Photoshopなどで開いた際のファイルサイズ
主画像
別カット
関連画像